Business Context and Reporting Period
Company: BillionToOne, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 12, 2026
Reporting Period: The filing addresses the full year ended December 31, 2025, and initiates guidance for the full year 2026.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that the Company has issued a press release (Exhibit 99.1) containing these details, but the figures themselves are not embedded in the 8-K text provided.
Material Changes
No specific material changes in financial condition or operations are detailed in the text of this filing. The primary event is the reiteration of 2025 guidance and the initiation of 2026 guidance.
Guidance, Outlook, and Management Commentary
- 2025 Guidance: The Company reiterated its full-year guidance for the period ended December 31, 2025.
- 2026 Guidance: The Company initiated its full-year guidance for 2026.
- Investor Presentation: The Company will present at the 2026 J.P. Morgan Healthcare Conference on January 12, 2026. The presentation materials are available on the Company's Investor Relations website.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 12, 2026) for specific revenue, profit, and margin figures for 2025 and 2026.
- Access the 2026 J.P. Morgan Healthcare Conference presentation on the Company's website for detailed management commentary and strategic outlook.
- Verify the specific numerical targets for the newly initiated 2026 guidance against historical performance.